Page last updated: 2024-09-02

1-hexadecyl-2-acetyl-glycero-3-phosphocholine and f-chemotactic peptide

1-hexadecyl-2-acetyl-glycero-3-phosphocholine has been researched along with f-chemotactic peptide in 2 studies

Compound Research Comparison

Studies
(1-hexadecyl-2-acetyl-glycero-3-phosphocholine)
Trials
(1-hexadecyl-2-acetyl-glycero-3-phosphocholine)
Recent Studies (post-2010)
(1-hexadecyl-2-acetyl-glycero-3-phosphocholine)
Studies
(f-chemotactic peptide)
Trials
(f-chemotactic peptide)
Recent Studies (post-2010) (f-chemotactic peptide)
9,1561875527904

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Healy, CT; Moreira-Ludewig, R1
Advani, SH; Bhisey, AN; Kumar, A; Naik, NR; Radhika, V; Thennarasu, S1

Other Studies

2 other study(ies) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and f-chemotactic peptide

ArticleYear
A rapid microtiter plate method for the detection of lysozyme release from human neutrophils.
    Journal of pharmacological and toxicological methods, 1992, Volume: 27, Issue:2

    Topics: Amino Acid Sequence; Benzophenones; Cell Separation; Complement C5a; Humans; Leukotriene B4; Methods; Molecular Sequence Data; Muramidase; Neutrophils; Oligopeptides; Platelet Activating Factor; Protamines

1992
Granulocytes from chronic myeloid leukemia (CML) patients show differential response to different chemoattractants.
    American journal of hematology, 1996, Volume: 52, Issue:3

    Topics: Chemotactic Factors; Humans; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukotriene B4; N-Formylmethionine Leucyl-Phenylalanine; Neutrophils; Oligopeptides; Platelet Activating Factor; Receptors, Formyl Peptide; Receptors, Immunologic; Receptors, Peptide; Reference Values

1996